[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368057-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368057-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","spatial-metabolomics-atlas-in-the-progression-of-oral-squamous-cell-carcinoma","Spatial metabolomics atlas in the progression of oral squamous cell carcinoma","","Spatial metabolomics study investigates the dynamic metabolic changes during oral squamous cell carcinoma (OSCC) progression using desorption electrospray ionisation mass spectrometry imaging (DESI-MSI). Eight matched OSCC samples were analyzed to screen differential metabolites with MetaboAnalyst and to conduct metabolic pathway analysis. Key pathways and enzymes were validated by immunohistochemistry in an additional 60 OSCC patients, and DEGS1 functional effects were tested using OSCC knockdown cell lines in vitro. Results link sphingolipid metabolism and unsaturated fatty acid biosynthesis to OSCC progression, and high DEGS1 indicates poorer survival and higher tumor grade.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/spatial-metabolomics-atlas-in-the-progression-of-oral-squamous-cell-carcinoma/368057/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/spatial-metabolomics-atlas-in-the-progression-of-oral-squamous-cell-carcinoma/368057.png","ImageObject",300,407,{"name":42,"@type":43},"anakgang17","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What technology was used to visualize OSCC metabolic progression?","Question",{"text":63,"@type":64},"DESI-MSI (desorption electrospray ionisation mass spectrometry imaging) was used to capture spatial metabolic characteristics across OSCC stages.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were differential metabolites and metabolic pathways identified?",{"text":68,"@type":64},"MetaboAnalyst was used to screen differential metabolism between tissue groups and to perform metabolic pathway analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"Why is DEGS1 important in OSCC?",{"text":72,"@type":64},"DEGS1 was identified as a key enzyme in sphingolipid metabolism, associated with tumor carcinogenesis; high DEGS1 expression predicted worse overall and disease-free survival and was linked to tumor pathological grade.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368057,1790428024,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Zhao et al. Journal of Translational Medicine (2026) 24:21  \n[https://doi.org/10.1186/s12967-025-07421-2](https://doi.org/10.1186/s12967-025-07421-2)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nSpatial metabolomics atlas in the progression of oral squamous cell carcinoma  \nHuiting Zhao 1,2†, Wei Han3†, Chaowen Shi4, Guanfa Luo 1, Wen Lu 1, Yujuan Fu 1,2, Qingang Hu3, Xiaowei Song5, Zhengjun Shang6* and Xihu Yang 1,2*  \nAbstract  \nBackground Oral squamous cell carcinogenesis is a complex biological process, although some progress has been made in predicting the risk of malignant transformation of oral squamous cell carcinoma (OSCC) . We aimed to visualise the dynamic metabolic characteristics of the progression of OSCC using desorption electrospray ionisation mass spectrometry imaging (DESI-MSI) .  \nMethods Eight matched OSCC samples were analysed using DESI-MSI. MetaboAnalyst database was used to screen for differential metabolism, and perform metabolic pathway analysis. Key pathways and enzymes were validated using immunohistochemical (IHC) techniques in an additional 60 patients with OSCC. Knockdown OSCC cell  \nlines were constructed and functional experiments were carried out to elucidate the effect of key enzyme on the proliferation and migration of OSCC.  \nResults Spatial metabolomics revealed 55 differential metabolites between cancer and normal mucosal tissues, 59 between cancer and precancerous tissues, and 52 between precancerous and normal mucosal tissues. We further identified 30 metabolites that were either increased or decreased from normal tissues to precancerous lesions and then to cancer tissues. Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway analysis confirmed that sphingolipid metabolism and biosynthesis of unsaturated fatty acids are the main metabolic pathways involved in OSCC. Dihydroceramide desaturase (DEGS1) is the key enzyme in sphingolipid metabolism and is involved inceramide synthesis, which is closely related to tumour carcinogenesis. We further confirmed that high expression of DEGS1 predicts poor overall survival and disease-free survival, and is closely related to the pathological grade of the tumour. In multivariate COX regression analysis, high expression of DEGS1 in tumor cells was an independent risk factor for OS in OSCC patients. Moreover, we demonstrated that DEGS1 knockdown inhibited the proliferation and migration of OSCC cells in vitro.  \nConclusion Our study used DESI-MSI to uncover the progression of OSCC at the spatial metabolomics level, and discovered key metabolic molecules involved in the carcinogenesis of OSCC. Sphingolipid metabolism plays  \n†Huiting Zhao and Wei Han contributed equally to this work.  \n*Correspondence:  \nZhengjun Shang [shangzhengjun@hotmail.com](shangzhengjun@hotmail.com)[ ](shangzhengjun@hotmail.com)Xihu Yang [yangxihu1981@126.com](yangxihu1981@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http:/","cbCaikKPojgKNhOf","https://ap.wps.com/l/cbCaikKPojgKNhOf","pdf",4497536,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What technology was used to visualize OSCC metabolic progression?\",\"answer\":\"DESI-MSI (desorption electrospray ionisation mass spectrometry imaging) was used to capture spatial metabolic characteristics across OSCC stages.\"},{\"question\":\"How were differential metabolites and metabolic pathways identified?\",\"answer\":\"MetaboAnalyst was used to screen differential metabolism between tissue groups and to perform metabolic pathway analysis.\"},{\"question\":\"Why is DEGS1 important in OSCC?\",\"answer\":\"DEGS1 was identified as a key enzyme in sphingolipid metabolism, associated with tumor carcinogenesis; high DEGS1 expression predicted worse overall and disease-free survival and was linked to tumor pathological grade.\"}]","Spatial metabolomics atlas in the progression of oral squamous cell carcinoma | PDF",1790174712,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89b45be282d5f68e7c6e74a3f47fa034.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f18be998d8470b9f4feca330468b66d.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f98b185e8aa1efcd3623e288faac73ab.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14337746b2d3f19aa5a51b99296c47f3.webp",980,1306]